Company / Operating Income per Share
Traws Pharma, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$39.00
FY2024
5-year range
-$39.00 / -$0.20
FY2020-FY2024
Trend
-4058.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -4058% YoY in FY2024, a notable deviation from the 9-year average annual change of -657%.
Based on SEC 10-K filings.
-39.00 in FY2024.
Declined from $-0.79 to $-39.00 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share decreased 4058.0% year-over-year.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$39.00 | -4058.0% |
| FY2023 | -$0.94 | -18.8% |
| FY2022 | -$0.79 | +63.3% |
| FY2021 | -$2.15 | -1002.7% |
| FY2020 | -$0.20 | +95.2% |
| FY2019 | -$4.10 | +88.6% |
| FY2018 | -$35.84 | -922.2% |
| FY2017 | -$3.51 | +62.8% |
| FY2016 | -$9.41 | -220.5% |
| FY2015 | -$2.94 | -183.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026